Quantcast

Latest Abagovomab Stories

2014-10-30 08:35:51

Trial will test the potential synergy between a taxane and TTFields in the treatment of recurrent ovarian cancer ST. HELIER, Jersey, Oct. 30, 2014 /PRNewswire/ -- Novocure announced today that the first patient has been enrolled in the INNOVATE study, an open-label pilot clinical study of TTFields together with weekly paclitaxel for patients with recurrent ovarian cancer. "The INNOVATE study builds on published preclinical research that shows clear synergy between TTFields and...

2014-06-09 12:31:07

TSX Venture: QPT EDMONTON, June 9, 2014 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, reports today that patient enrollment has been completed in the Company's Phase IIb clinical trial of its lead immunotherapy product candidate Oregovomab for the treatment of Ovarian Cancer. "I am pleased that we have reached this important milestone in our clinical program"...

2014-05-20 23:02:55

New comprehensive research report “Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies” elaborated by GBI Research is now available at MarketPublishers.com. According to the study, the global ovarian cancer therapeutics market is anticipated to post a 3.4% CAGR through 2020. London, UK (PRWEB) May 20, 2014 At present, the overall ovarian cancer therapeutics market is led by the use of...

2013-10-07 23:18:13

Reportbuyer.com just published a new market research report: Therapies and Diagnostics for Ovarian Cancer. London (PRWEB) October 07, 2013 STUDY GOALS AND OBJECTIVES This report, Therapies and Diagnostics for Ovarian Cancer, provides an overview of the current and potential global market for ovarian cancer and treatments and testing technologies. The report provides comprehensive information on ovarian cancer and highlights treatment guidelines. It identifies and analyses the key trends...

2013-04-08 12:26:08

A new antibody-guided drug has shown promising activity in a phase I trial involving ovarian cancer patients with platinum drug-resistant disease, researchers from Dana-Farber Cancer Institute will report today at the annual meeting of the American Association for Cancer Research. The findings (abstract LB-290) will be discussed at a press conference on Saturday, April 06, 2013, 1:00 p.m., ET, in Room 153, in the Washington Convention Center and later at an oral presentation on Tuesday, April...

2013-01-11 02:20:01

Tokyo, Jan 11, 2013 - (JCN Newswire) - Eisai Co., Ltd. announced today the preliminary results of its global Phase III study (Study FAR 131, MORAb-003-004) of farletuzumab (MORAb-003), an investigational compound under development at its U.S. subsidiary, Morphotek, Inc., in patients with platinum-sensitive epithelial ovarian cancer in first relapse.The study was a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparative study of 1,100 patients with...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.